| 臺大學術典藏 |
2018 |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Chiun Hsu;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Chiun Hsu; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2017 |
Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis
|
Hsiue E.H.-C.; Hsiue E.H.-C.;Chiun Hsu;Tseng L.-H.;Lu T.-P.;Kuo K.-T.; Chiun Hsu; Tseng L.-H.; Lu T.-P.; Kuo K.-T. |
| 臺大學術典藏 |
2017 |
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
|
El-Khoueiry A.B.; Sangro B.; Yau T.; Crocenzi T.S.; Kudo M.; CHIUN HSU; Kim T.-Y.; Choo S.-P.; Trojan J.; Welling T.H.; 3rd, Meyer T.; Kang Y.-K.; Yeo W.; Chopra A.; Anderson J.; dela Cruz C.; Lang L.; Neely J.; Tang H.; Dastani H.B.; Melero I. |
| 臺大學術典藏 |
2017 |
Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy
|
Lin Y.-Z.; Ou D.-L.; Chang H.-Y.; Lin W.-Y.; CHIUN HSU; Chang P.-L. |
| 臺大學術典藏 |
2016 |
Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges
|
Lu L.-C.; Hsu C.-H.; CHIUN HSU; Cheng A.-L. |
| 臺大學術典藏 |
2015 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Oh D.-Y.; Chiun Hsu; Chen J.-S.; Chen L.-T.; Orlando M.; Kim J.S.; Lim H.Y.; Park J.O.; Park J.O.;Oh D.-Y.;Chiun Hsu;Chen J.-S.;Chen L.-T.;Orlando M.;Kim J.S.;Lim H.Y. |
| 臺大學術典藏 |
2015 |
Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Cheng A.-L.Ann-Lii; CHIUN HSU; Ou D.-L.; Shyue S.-K.; Lin L.-I.; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S. |
| 中國醫藥大學 |
2014-06 |
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
|
(Chiun Hsu);(Hsiao-Hui Tsou);(Shyh-Jer Lin);(Ming-Chung Wang);(Ming Yao);(Wen-Li Hwang);(Woei-Yau Kao);邱昌芳(Chang-Fang Chiu);(Sheng-Fung Lin);(Johnson Lin);(Cheng-Shyong Chang);(Hwei-Fang Tien);(Tsang-Wu Liu);(Pei-Jer Chen)*;(Ann-Lii Cheng) |
| 臺大學術典藏 |
2014 |
Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma
|
Chang M.-C.; Chen C.-H.; Liang J.-D.; Tien Y.-W.; Chiun Hsu; Wong J.-M.; Chang Y.-T. |
| 臺大學術典藏 |
2014 |
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: The phase II RACHEL study
|
Ciuleanu T.; Klughammer B.; Meng X.; Csutor Z.; Fittipaldo A.; Zeaiter A.; Lipp R.; Stemmer S.M.; CHIUN HSU; Tham C.K.; Van Cutsem E.; Li C.-P.; Nowara E.; Aprile G.; Moore M.; Federowicz I.; Van Laethem J.-L. |
| 臺大學術典藏 |
2014 |
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin
|
Ou D.-L.; Lee B.-S.; Lin L.-I.; Liou J.-Y.; Liao S.-C.; CHIUN HSU; Cheng A.-L. |
| 臺大學術典藏 |
2014 |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Cheng A.-L.; Yeh K.-H.; Su W.-C.; Chao Y.; Shen Y.-C.; Li C.-P.; Yen C.-J.; CHIUN HSU; Lin Y.-L.; Lin Z.-Z.; Chen L.-T. |
| 臺大學術典藏 |
2014 |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
CHIUN HSU; Chang S.-Y.; Chien S.-F.; Chen Y.-C.; Hu F.-C.; Yang J.C.-H.; Cheng A.-L.; Yeh K.-H.; Chen I.-C.; Kao H.-F. |
| 臺大學術典藏 |
2014 |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; CHIUN HSU; Cheng A.-L. |
| 中國醫藥大學 |
2013-03 |
14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma
|
(Tzu-An Liu);(Yee-Jee Jan);(Bor-Sheng Ko);(Shu-Man Liang);(Shyh-Chang Chen);(John Wang);(Chiun Hsu);(Yao-Ming Wu);劉俊揚(Jun-Yang Liou)* |
| 臺大學術典藏 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; CHIUN HSU; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2013 |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU; Cheng A.-L. |
| 臺大學術典藏 |
2012 |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2012 |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; CHIUN HSU; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2012 |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma
|
Chen C.-H.; Chang Y.-H.; Chang J.S.; Chen L.-T.; CHIUN HSU; Ch'Ang H.-J. |
| 臺大學術典藏 |
2012 |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; CHIUN HSU; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2011 |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Chiun Hsu; Kuo W.H.; Lu Y.S.; Cheng A.L.; Lien H.C.; Chen I.C. ;Lin C.H. ;Huang C.S. ;Lien H.C. ;Chiun Hsu ;Kuo W.H. ;Lu Y.S. ;Cheng A.L.; Chen I.C.; Lin C.H.; Huang C.S. |
| 臺大學術典藏 |
2011 |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
Kuo Y.-H.; Tien Y.-W.; CHIUN HSU; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.; Yang S.-H. |
| 臺大學術典藏 |
2011 |
End-of-life care for cancer patients in Taiwan
|
CHIUN HSU |
| 臺大學術典藏 |
2011 |
High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy
|
Shao Y.-Y.; Lin Z.-Z.; Chen T.-J.; CHIUN HSU; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
